BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23295306)

  • 1. Low serum concentrations of anti-Müllerian hormone are common in 53 female childhood cancer survivors.
    Miyoshi Y; Ohta H; Namba N; Tachibana M; Miyamura T; Miyashita E; Hashii Y; Oue T; Isobe A; Tsutsui T; Kimura T; Ozono K
    Horm Res Paediatr; 2013; 79(1):17-21. PubMed ID: 23295306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
    Lunsford AJ; Whelan K; McCormick K; McLaren JF
    Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
    Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
    Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian function in female survivors of childhood malignancies.
    El-Shalakany AH; Ali MS; Abdelmaksoud AA; Abd El-Ghany S; Hasan EA
    Pediatr Hematol Oncol; 2013 May; 30(4):328-35. PubMed ID: 23574301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer].
    Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
    Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
    Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
    Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients.
    Bozza C; Puglisi F; Lambertini M; Osa EO; Manno M; Del Mastro L
    Endocr Relat Cancer; 2014 Feb; 21(1):R51-65. PubMed ID: 24292601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Detection of Ovarian Dysfunction by Anti-Mullerian Hormone in Adolescent and Young Adult-Aged Survivors of Childhood Cancer.
    George SA; Williamson Lewis R; Schirmer DA; Effinger KE; Spencer JB; Mertens AC; Meacham LR
    J Adolesc Young Adult Oncol; 2019 Feb; 8(1):18-25. PubMed ID: 30281375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
    van den Berg MH; Overbeek A; Lambalk CB; Kaspers GJL; Bresters D; van den Heuvel-Eibrink MM; Kremer LC; Loonen JJ; van der Pal HJ; Ronckers CM; Tissing WJE; Versluys AB; van der Heiden-van der Loo M; Heijboer AC; Hauptmann M; Twisk JWR; Laven JSE; Beerendonk CCM; van Leeuwen FE; van Dulmen-den Broeder E;
    Hum Reprod; 2018 Aug; 33(8):1474-1488. PubMed ID: 29982673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels.
    Panidis D; Katsikis I; Karkanaki A; Piouka A; Armeni AK; Georgopoulos NA
    Med Hypotheses; 2011 Oct; 77(4):649-53. PubMed ID: 21807466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimullerian hormone in cases of different reproductive pathologies.
    Barbakadze L; Kristasashvili J
    Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy.
    Lee DY; Park YH; Lee JE; Choi D
    Breast Cancer Res Treat; 2018 Oct; 171(3):649-656. PubMed ID: 29943121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadal Function in Female Adolescent and Young Adult Survivors of Childhood Cancer.
    Jin HY; Lee JA; Park M; Park HJ
    Cancer Res Treat; 2023 Jul; 55(3):992-1000. PubMed ID: 36731461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay.
    Decanter C; Peigne M; Mailliez A; Morschhauser F; Dassonneville A; Dewailly D; Pigny P
    Fertil Steril; 2014 Aug; 102(2):483-7. PubMed ID: 24951363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.
    Visser JA; Hokken-Koelega AC; Zandwijken GR; Limacher A; Ranke MB; Flück CE
    Hum Reprod; 2013 Jul; 28(7):1899-907. PubMed ID: 23539612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian function in young women after anticancer treatment in childhood].
    Krawczuk-Rybak M; Leszczyńska E; Zelazowska-Rutkowska B; Wysocka J
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1028-34. PubMed ID: 19531821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
    Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
    Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.